MedTrace Logo

Monocyte Soluble Activation Markers sCD14 and sCD163 in Children With Type 1 Diabetes Mellitus

NCT05347836 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2022-04-26

No results posted yet for this study

Summary

The study aims to compare serum levels of sCD14 and sCD163 in children with type 1 Diabetes Mellitus with healthy controls, study the distribution of monocyte subsets in children with T1DM , correlate monocyte subsets and their soluble activation markers sCD14 and sCD163 with parameters reflecting islet β-cell insufficiency in children with T1DM.

Conditions

  • Type1diabetes

Interventions

DIAGNOSTIC_TEST

ELISA

Determination of serum levels of sCD14 and sCD163 using ELISA

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
5 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2023-07-01
Completion
2023-08-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05347836 on ClinicalTrials.gov